PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)

• Chi-Yang Tseng,
• Ya-Chu Yu,
• Chia-Hung Kuo,
• Kuan-Wei Su,
• Kam Hoi Ho,
• Da-Liang Ou,
• Hsin-An Hou,
• Liang-In Lin

Affiliations

Chi-Yang Tseng

1 National Taiwan University, Clinical Laboratory Sciences and Medical Biotechnology, Taipei, Taiwan

Ya-Chu Yu

2 National Taiwan University, Clinical Laboratory Sciences and Medical Biotechnology, Taipei, Taiwan

Chia-Hung Kuo

2 National Taiwan University, Clinical Laboratory Sciences and Medical Biotechnology, Taipei, Taiwan

Kuan-Wei Su

2 National Taiwan University, Clinical Laboratory Sciences and Medical Biotechnology, Taipei, Taiwan

Kam Hoi Ho

2 National Taiwan University, Clinical Laboratory Sciences and Medical Biotechnology, Taipei, Taiwan

Da-Liang Ou

3 National Taiwan University, Oncology, Taipei, Taiwan

Hsin-An Hou

4 National Taiwan University, Medicine, Taipei, Taiwan

Liang-In Lin

2 National Taiwan University, Clinical Laboratory Sciences and Medical Biotechnology, Taipei, Taiwan